In the field of allergy testing, the Medical Division developed a simultaneous, multiple-Item, and rapid testing system with a small amount of blood to reduce stress on patients and in 2023, commercialized SiLIS series (Simultaneous Luminescence Immunoassay System).
In the future, we will contribute to society by proposing new product groups to primary care based on this technology and improving QOL(Quality of Life) from a preventive medicine perspective.